Featured news
Year-End Report 2024 Nanologica AB (publ)
FINANCIAL SUMMARY • Net sales for the fourth quarter amounted to SEK 6,715 thousand (75) and for the full year to SEK 14,538 thousand (1,443) • Operating loss for the quarter amounted to SEK -11,890 thousand (-35,638) and for the full year to SEK -59,255 thousand (-69,963). For the full year, operating profit was affected by write-downs of tangible and intangible assets totaling SEK 10,434 thousand (14,523). • Loss after tax for the quarter amounted
Change of Dates for Year-End Report 2024 for Nanologica AB
Due to technical reasons, Nanologica AB moves the year-end report for 2024 to Friday, February 14. The year-end report will be published on the company’s website at approximately 08.10. See press release
NANOLOGICA RECEIVES ORDER OF NLAB SAGA® WORTH APPX SEK 8.5 MILLION FROM RECURRING CUSTOMER IN CHINA
Nanologica has received yet another order for the company’s silica-based purification media NLAB Saga® from the Chinese pharmaceutical manufacturer Chengdu Shengnuo Biopharm Co. (“Shengnuo”). The order is worth approximately SEK 8.5 million and the customer uses Nanologica’s purification media in the production of a GLP-1 analogue. Since June 2024, Shengnuo has placed five orders of NLAB Saga® with a total value of approximately SEK 18 million. ”The Chinese market is very interesting for us and
Nanologica Receives Order on NLAB Saga® Valued at approx SEK 1,9 Million
Nanaologica Receives Order on NLAB Saga® Valued at approx. SEK 1,9 Million from Returning Customer in China Nanologica has received another order for the company’s silica-based purification media NLAB Saga® from a returning customer in China. This is the fourth order since June from this customer who uses NLAB Saga® in the production of a GLP-1 analogue. “The fact that this customer is now placing another order for NLAB Saga® confirms once again that our
Interim Report Q3 2024 Nanologica AB (publ)
FINANCIAL SUMMARY Net sales for the third quarter amounted to SEK 611 thousand (342) and for the nine-month period to SEK 7,822 thousand (1,368) Operating loss for the quarter amounted to SEK -22,203 thousand (-10,292) and for the nine-month period to SEK -47,365 thousand (-34,324) Loss before tax for the quarter amounted to SEK -23,701 thousand (-11,554) and for the nine-month period to SEK -51,561 thousand (-38,318) Earnings per share before and after dilution were